EUCTR2008-001499-55-FI进行中（未招募）不适用
Treatment Monitoring of Advanced Colorectal cancer with 18F-FDG PET/CT
Turku PET Centre0 个研究点目标入组 140 人开始时间: 2008年3月19日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
已完成
不适用
Colomid: Midkine as a predictive marker in colorectal cancerACTRN12613000111774Calvary Mater Newcastle Hospital33
尚未招募
不适用
Refractory advanced colorectal cancer in the treatment with integrated traditional Chinese and western medicine: a multi-center clinical studycolorectal cancerITMCTR2200006741onghua Hospital, Shanghai University of Traditional Chinese Medicine
终止
不适用
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CTColorectal CancerNCT00823810Turku University Hospital20
招募中
不适用
Treatment of Recurrent and Advance Colorectal Cancer (TRACC): A prospective multi-site registryAdvanced Colorectal CancerACTRN12618000404224Biogrid3,000